Sensei Biotherapeutics (SNSE) Stock Statistics & Valuation Metrics

Sensei Biotherapeutics has a market cap or net worth of $11.38M. The enterprise value is $35.99M.

Sensei Biotherapeutics has 1,260,403 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sensei Biotherapeutics’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -77.23%.

The current PE Ratio of Sensei Biotherapeutics is -0.41. Sensei Biotherapeutics’s PEG ratio is -0.05.

In the last 12 months, Sensei Biotherapeutics had revenue of 0.00 and earned -30.16M in profits. Earnings per share was -1.20.

In the last 12 months, operating cash flow was -24.15M and capital expenditures -109.00K, giving a free cash flow of -24.26M billion.

Sensei Biotherapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Sensei Biotherapeutics upcoming earnings date is Jul 31, 2025, Before Open (Confirmed).

Sensei Biotherapeutics as a current ratio of 7.70, with Debt / Equity ratio of 7.77%

In the past 12 months, Sensei Biotherapeutics has paid 0.00 in taxes.

Sensei Biotherapeutics EV to EBITDA ratio is -0.19, with an EV/FCF ratio of -0.25.

Sensei Biotherapeutics has $34.33M in cash and marketable securities with $3.21M in debt, giving a net cash position of -$31.12M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sensei Biotherapeutics is $20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy